Related Experiment Videos
[Our experience treating deep mycoses with amphoglucamine]
Antibiotiki
|February 1, 1981
Summary
Amphoglucamine effectively treated deep mycoses in 36 patients without observed toxicity. However, potential fungal elements after treatment suggest the need for optimized amphoglucamine dosage for complete eradication.
Area of Science:
- Mycology
- Pharmacology
- Infectious Diseases
Context:
- Deep mycoses represent serious fungal infections.
- Antifungal drug development is crucial for treating invasive fungal diseases.
- Patient tolerance and drug efficacy are key treatment considerations.
Purpose:
- To evaluate the efficacy and safety of amphoglucamine for treating deep mycoses.
- To assess patient tolerance to amphoglucamine administered via inhalation or orally.
- To identify potential limitations or areas for improvement in amphoglucamine therapy.
Summary:
- Amphoglucamine was administered to 36 patients with deep mycoses through inhalations or oral routes.
- No toxic effects were observed, and patients reported satisfactory tolerance and clinical improvement.
- Post-treatment fungal elements were detected, indicating possible underdosing with oral amphoglucamine tablets.
Impact:
- Amphoglucamine shows promise as a well-tolerated antifungal agent for deep mycoses.
- The study highlights the importance of appropriate drug dosage for achieving complete fungal clearance.
- Findings may guide future research on optimizing amphoglucamine dosing regimens.